locametz
novartis europharm limited - gozetotide - radionuklidno slikanje - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
donepezil synthon 5 mg filmsko obložene tablete
synthon bv - donepezil - filmsko obložena tableta - donepezil 4,56 mg / 1 tableta - donepezil
donepezil synthon 10 mg filmsko obložene tablete
synthon bv - donepezil - filmsko obložena tableta - donepezil 9,12 mg / 1 tableta - donepezil
pemetreksed teva 500 mg prašek za koncentrat za raztopino za infundiranje
teva b.v. - pemetreksed - prašek za koncentrat za raztopino za infundiranje - pemetreksed 500 mg / 1 viala - pemetreksed
pemetreksed teva 1000 mg prašek za koncentrat za raztopino za infundiranje
teva b.v. - pemetreksed - prašek za koncentrat za raztopino za infundiranje - pemetreksed 1000 mg / 1 viala - pemetreksed
pemetreksed teva 100 mg prašek za koncentrat za raztopino za infundiranje
teva b.v. - pemetreksed - prašek za koncentrat za raztopino za infundiranje - pemetreksed 100 mg / 1 viala - pemetreksed